Sander, D;Winbeck, K;Etgen, T;Landgrebe, M;Conrad, B
New aspects of stroke prevention: Modern differential therapy with platelet inhibitors
NERVENHEILKUNDE
2003
22
6
295-+

Ceballos-Baumann, AO
Dementia in Parkinsonism: Clinical and therapeutic aspects
NERVENHEILKUNDE
2003
22
6
287-+

Ceballos-Baumann, A
The role of EMG guidance in botulinum toxin (BTX) therapy
Klinische Neurophysiologie
2003
34
3
138-144

Boecker, H;Haussermann, P;Drzezga, A;Conrad, B;Schwaiger, M;Ceballos-Baumann, A
The metabolic correlate of dementia in Parkinson disease: A fluorine-18-fluorode-oxyglucose (FDG) PET study
J Nucl Med
2003
44 Suppl.
5
237P-237P

Sander, D;Grafman, J;Zalla, T
The human amygdala: an evolved system for relevance detection.
Rev Neurosci
2003
14
4
303-16

Sabri, O;Owega, A;Schreckenberger, M;Sturz, L;Fimm, B;Kunert, P;Meyer, PT;Sander, D;Klingelhöfer, J
A truly simultaneous combination of functional transcranial Doppler sonography and H(2)(15)O PET adds fundamental new information on differences in cognitive activation between schizophrenics and healthy control subjects.
J Nucl Med
2003
44
5
671-81

Schmidt, B;Czosnyka, M;Raabe, A;Yahya, H;Schwarze, JJ;Sackerer, D;Sander, D;Klingelhöfer, J
Adaptive noninvasive assessment of intracranial pressure and cerebral autoregulation.
Stroke
2003
34
1
84-9

Ceballos-Baumann, AO
Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT.
J Neurol
2003
250 Suppl
I15-23

Ceballos-Baumann, A
[Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?]
MMW Fortschr Med
2003
145 Suppl
99-102

Heckmann, M;Teichmann, B;Schröder, U;Sprengelmeyer, R;Ceballos-Baumann, AO
Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear.
J Am Acad Dermatol
2003
49
2
213-6